Intranasal bivalent vaccine platform for SARS-CoV-2 and RSV
TS-075189 — PROBLEM
SARS-CoV-2 and respiratory syncytial virus (RSV) drive significant global morbidity. New SARS-CoV-2 Omicron variants are causing frequent and often severe infections, while RSV remains a leading cause of severe respiratory disease in infants and young children, older adults, and immunocompr…
- College: College of Veterinary Medicine
- Inventors: Li, Jianrong; Liang, Xueya; Xu, Jiayu
- Licensing Officer: Willson, Christopher
A next generation intranasal trivalent Measles, Mumps and Covid vaccine
TS-064189 — The Need
The current global landscape demands innovative solutions to address the urgent need for a safe and efficacious SARS-CoV-2 vaccine, particularly for the vulnerable population of infants and children under 12 years old. Existing vaccines face challenges in terms of durability, cost, and sta…
- College: College of Veterinary Medicine
- Inventors: Li, Jianrong; Xu, Jiayu; Zhang, Yuexiu
- Licensing Officer: Willson, Christopher
